[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-366295-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-366295-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","cxcl1-and-cxcl8-reliable-and-feasible-biomarkers-differentiating-intrapulmonary-metastasis-from-multiple-primary-neoplasms-in-non-small-cell-lung-cancers","CXCL1 and CXCL8 - Reliable and feasible biomarkers differentiating intrapulmonary metastasis from multiple primary neoplasms in non-small cell lung cancers","","Objective: In non-small cell lung cancer, distinguishing intrapulmonary metastasis (IPM) from multiple primary lung cancer (MPLC) often requires combining histopathological and genomic information. This study identifies reliable biomarkers by integrating comprehensive genomic profiling and targeted RNA sequencing. Methods: Retrospective tissue collection from at least two lesions in 34 patients enabled genomic and transcriptomic investigation. Results: CXCL1 and CXCL8 are significantly upregulated in IPM. Conclusions: CXCL1 and CXCL8 expression in any patient tumor lesion, and their transcriptional levels, provide dependable, practical indicators of IPM.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/cxcl1-and-cxcl8-reliable-and-feasible-biomarkers-differentiating-intrapulmonary-metastasis-from-multiple-primary-neoplasms-in-non-small-cell-lung-cancers/366295/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/cxcl1-and-cxcl8-reliable-and-feasible-biomarkers-differentiating-intrapulmonary-metastasis-from-multiple-primary-neoplasms-in-non-small-cell-lung-cancers/366295.png","ImageObject",300,407,{"name":42,"@type":43},"Pentious","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-14","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What biomarkers does the study identify for distinguishing IPM from MPLC?","Question",{"text":63,"@type":64},"The study finds that CXCL1 and CXCL8 expression is significantly upregulated in intrapulmonary metastasis. CXCL1 and CXCL8 levels in any tumor lesion can reliably indicate IPM.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were IPM and MPLC cases determined in the patient cohort?",{"text":68,"@type":64},"Tissues were collected from at least two lesions in 34 patients. Pathologic classification used the Martini-Melamed (M-M) criteria, identifying pathologic MPLC (pMPLC) and pathologic IPM cases accordingly.",{"name":70,"@type":61,"acceptedAnswer":71},"What sequencing approaches were integrated to evaluate differences between IPM and MPLC?",{"text":72,"@type":64},"The research combines comprehensive genomic profiling (CGP) with targeted RNA sequencing. Genomic and transcriptomic investigations were used to assess mutations and gene expression pathways.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},366295,1790380649,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":123,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},1374404730887,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","CXCL1 and CXCL8: Reliable and feasible biomarkers differentiating intrapulmonary metastasis from multiple primary neoplasms in non-small cell lung cancers  \nCancer Biomarkers Vol. 42(4): 1–10 © The Author(s) 2025 Article reuse guidelines:  \n[sagepub.com/journals-permissions](sagepub.com/journals-permissions)[ ](sagepub.com/journals-permissions)[DOI: 10.1177/18758592241308730](DOI: 10.1177/18758592241308730)[ ](DOI: 10.1177/18758592241308730)[journals.sagepub.com/home/cbm](journals.sagepub.com/home/cbm)  \nAo Liu 1 , Tianlin Sun2, Tong Qiu 1, Yunqing Chen3, Huiyang Qi3, Wenxing Du 1, Zhe Wu 1, Zhan Huang2, Wenqing Su2, Changbin Zhu2 and Wenjie Jiao4  \nAbstract  \nObjective: In NSCLC, the main approach to differentiate between intrapulmonary metastases (IPM) and multiple primary lung cancer (MPLC) is to integrate histopathological and genomic information. Here, we identiﬁed viable biomarkers that can distinguish IPM from MPLC by integrating comprehensive genomic proﬁling (CGP) and targeted RNA sequencing. Methods: We retrospectively collected tissues from at least two lesions in 34 patients. 29 and 5 out of 34 patients determined as pathologic MPLC (pMPLC) and pathologic IPM, respectively, according to Martini-Melamed criteria (M-M criteria). A comprehensive investigation at genomic and transcriptomic level was conducted.  \nResults: Nine of the 29 pMPLCs shared trunk mutations in their lesions and were consequently reclassiﬁed as IPM. Survival analyses revealed that classiﬁcation integrated M-M criteria and mutational proﬁling could distinguish IPM/ MPLC more accurately. Further exploration at the transcriptomic level revealed elevated expression levels of genes related to epithelial-mesenchymal transition and immunomodulatory pathways in IPM. Notably, the expression of CXCL1 and CXCL8 was signiﬁcantly upregulated in IPM.  \nConclusions: We found that the expression of CXCL1 and CXCL8 in any tumor lesion within a patient could reliably indicate IPM. Additionally, assessing the transcriptional levels of CXCL1 and CXCL8 also provide a dependable and practical approach to identify IPM from MPLC.  \nKeywords  \nNon–small cell lung cancer, multiple primary lung cancer, intrapulmonary metastasis, next generation sequencing, biomarkers  \nReceived: 23 January 2024; accepted: 25 November 2024  \nIntroduction  \nLung cancer stands as the leading cause of cancer-related fatalities on a global scale. The advent of early screening methods, particularly low-dose computed tomography (LDCT), has facilitated the increased detection of multiple pulmonary lesions associated with lung cancer.1 These lesions, classiﬁed based on their origin, fall predominantly into two categories: multiple primary lung cancer (MPLC) and intrapulmonary metastasis (IPM)-related lung cancer. In contrast to IPM, MPLC refers to the occurrence of two or more primary lung cancers in different lobes or segments within one or both lungs of the same patient. Depending on the timing of their appearance, MPLC is further categorized as synchronous MPLC (sMPLC) or metachronous MPLC (mMPLC).2,3 The ability to distinguish between MPLC  \nand IPM carries signiﬁcant implications for tumour staging, treatment strategy, and prognosis. This differentiation is  \n1 Department of Thoracic Surgery, The Afﬁliated Hospital of Qingdao University, Qingdao, Shandong, China  \n2Department of Translational Medicine, Amoy Diagnostics Co., Ltd, Haicang District, Xiamen, China  \n3Department of Pathology, The Afﬁliated Hospital of Qingdao University, Shandong, China  \n4Department of Thoracic Surgery, The Afﬁliated Hospital of Qingdao University, Qingdao, Shandong, China  \nCorresponding author:  \nProfessor Wenjie Jiao, Department of Thoracic Surgery, The Afﬁliated Hospital of Qingdao University, No. 16 Jiangsu Road, Qingdao, Shandong 266003, China.  \nEmail: [jiaowj@qduhospital.cn](jiaowj@qduhospital.cn)  \nCreative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commo","cbCaieCO7SI0WwR0","https://ap.wps.com/l/cbCaieCO7SI0WwR0","pdf",1365736,"English","# Abstract\n## Objective\n## Methods\n## Results\n## Conclusions\n# Introduction","[{\"question\":\"What biomarkers does the study identify for distinguishing IPM from MPLC?\",\"answer\":\"The study finds that CXCL1 and CXCL8 expression is significantly upregulated in intrapulmonary metastasis. CXCL1 and CXCL8 levels in any tumor lesion can reliably indicate IPM.\"},{\"question\":\"How were IPM and MPLC cases determined in the patient cohort?\",\"answer\":\"Tissues were collected from at least two lesions in 34 patients. Pathologic classification used the Martini-Melamed (M-M) criteria, identifying pathologic MPLC (pMPLC) and pathologic IPM cases accordingly.\"},{\"question\":\"What sequencing approaches were integrated to evaluate differences between IPM and MPLC?\",\"answer\":\"The research combines comprehensive genomic profiling (CGP) with targeted RNA sequencing. Genomic and transcriptomic investigations were used to assess mutations and gene expression pathways.\"}]","CXCL1 and CXCL8 - Reliable and feasible biomarkers differentiating intrapulmonary metastasis from multiple primary neoplasms in non-small cell lung cancers | PDF",1790164651,25,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0952e73d0fe5363e62d7118da0d6bd8f.webp",983,1310,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/203956e9c8efcb919c90df9c9878b0d5.webp",982,1309,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b9f03ba3969c86e1d6ae791c26ac0b57.webp",981,1308,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/41e9b9a2abc10e94f920174d0f204f38.webp",980,1306]